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Catalytic activation of pre-substrates via dynamic
fragment assembly on protein templates
Edyta Burda1 & Jo¨rg Rademann1,2
Sensitive detection of small molecule fragments binding to deﬁned sites of biomacromole-
cules is still a considerable challenge. Here we demonstrate that protein-binding fragments
are able to induce enzymatic reactions on the protein surface via dynamic fragment ligation.
Fragments binding to the S1 pocket of serine proteases containing a nitrogen, oxygen or
sulphur nucleophile are found to activate electrophilic pre-substrates through a reversible,
covalent ligation reaction. The dynamic ligation reaction positions the pre-substrate molecule
at the active site of the protein thereby inducing its enzymatic cleavage. Catalytic activation
of pre-substrates is conﬁrmed by ﬂuorescence spectroscopy and by high-performance liquid
chromatography. The approach is investigated with 3 pre-substrates and 14 protein-binding
fragments and the speciﬁc activation and the templating effect exerted by the enzyme is
quantiﬁed for each protease–fragment–pre-substrate combination. The described approach
enables the site-speciﬁc identiﬁcation of protein-binding fragments, the functional char-
acterization of enzymatic sites and the quantitative analysis of protein template-assisted
ligation reactions.
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F
ragment-based development of protein ligands has been
recognized over the last years as a powerful strategy to
identify molecules with an optimized ﬁt to protein-binding
pockets, providing ligands with reduced molecular weight and
with higher ligand efﬁciency, thereby possibly improving the
bioavailability, cell permeability and metabolic stability of drug
molecules1–8. Scrutinizing the chemical space of small molecule
fragments—instead of screening large libraries of drug-like
molecules—requires considerably smaller chemical libraries for
covering the chemical space and thus enables to identify and
optimize hit ligands with less effort for testing and chemical
synthesis.
There are, however, speciﬁc challenges implicated in the
fragment-based drug discovery process. Many primary fragment
hits possess low, often millimolar afﬁnities to the protein target
resulting from the small contact area and the low number of
binding interactions of fragments compared with larger mole-
cules. As a consequence, high concentrations of fragments have to
be used in the bioassays, which can interfere with the reliable
read-out of classical biochemical test systems. To circumvent this
problem, biophysical methods have been employed for the
detection of protein-binding fragments, using, for example,
nuclear magnetic resonance (NMR) spectroscopy9,10 or X-ray
diffraction of protein crystals11–14. Next, primary fragment hits
with low afﬁnity have to be extended to fragment combinations to
attain sufﬁcient activity—a process requiring the systematic
modiﬁcation of hits by applying tools and methods of
medicinal chemistry. Realistically, this optimization process can
be more time-consuming and uncertain in its outcome than the
initial discovery of fragment hits. Fragment combinations have
been synthesized and tested not only for direct inhibitor
screening, but also for the screening of substrate libraries.
Active substrates can then serve as a starting point for the
development of enzyme inhibitors following a seminal concept in
medicinal chemistry15,16.
Dynamic ligation screening (DLS) has been introduced as an
approach for the sensitive, site-selective detection of protein-
binding fragments17. In this method, a chemically reactive
protein ligand serves as a directing probe for the screening of
fragment libraries at a spatially deﬁned protein site18. Reversible
formation of a covalent bond between the directing probe and a
nucleophilic fragment enables the sensitized detection of
low-afﬁnity fragments with millimolar activity while testing
at lower concentrations of 10–100 mM. This sensitizing effect
results from the templated assembly of protein ligands on the
protein surface. As a consequence, standard biochemical assays
can be applied for the detection of low-afﬁnity fragments,
for example, the enzymatic conversion of a ﬂuorogenic substrate
or ﬂuorescence polarization for a binding assay19. DLS provides
fewer hits than biophysical assays, as only fragments with a
ﬁtting spatial orientation in the ligation product are detected as
actives. Active fragment combinations were identiﬁed and
optimized iteratively, with respect to afﬁnity or, if second-site-
speciﬁc fragments are scrutinized with sets of proteins, with
respect to speciﬁcity20. Other than in biophysical assays,
nanomolar protein concentrations are sufﬁcient and large
collections of nucleophilic fragments can be tested in small
volumes of liquids on microtitre plates. Conceptually, DLS
constitutes a speciﬁc application of dynamic covalent
chemistry, which has been deﬁned as that branch of organic
chemistry studying compounds formed reversibly in
thermodynamic equilibrium6,21. Therefore in principal all
dynamic ligation reactions should be applicable to fragment
ligation assays, yielding, for example, imines22–24,
hydrazones25,26, hemiacetals27,28, hemithioacetals29, acetals30,31,
thioesters32 or Michael addition products33.
In this paper we wish to explore a novel approach for the
identiﬁcation of protein-binding fragment assemblies formed by
dynamic covalent chemistry introduced here as the ‘pre-substrate
concept’. Central idea of this approach is to employ completely
inactive reporter probes denominated as ‘pre-substrates’ for the
detection of protein-binding fragments and/or to use such probes
for the detection or discovery of hitherto unknown reactive sites
on protein surfaces. Pre-substrates are supposed to contain a
reactive site, for example, an electrophile like aldehyde or Michael
acceptor moiety for covalent ligation with various nucleophiles
and an N-acylated reporter dye such as the ﬂuorophore 7-amino-
4-methylcoumarin (AMC) for detection. As N-deacylation of the
acylated 7-amino group in AMC shifts the ﬂuorescence emission
of the coumarin dye to longer wavelengths, the cleavage of this
amide bond by a hydrolytic enzyme is detectable as a time-
dependent increase in ﬂuorescence. In this contribution we
demonstrate that electrophilic pre-substrates are valuable tools
for the detection of biologically active fragments in a ﬂuores-
cence-based enzyme assay and that the assay system enables the
quantiﬁcation of the templating effect exerted by the target
protein for each fragment–pre-substrate combination.
Results
The concept of pre-substrate activation. To establish the assay
system, serine proteases were selected as model targets (Fig. 1).
Nucleophilic fragments, which bind to the S1 substrate-binding
pocket of a serine protease were expected to assemble with a
pre-substrate in a protein-templated reaction under formation of
a covalent bond between the fragment nucleophile with the
electrophile of the pre-substrate. In case of an optimal ﬁt to the
protein, this fragment assembly should position the amide bond
of the pre-substrate at the active site of the protein and thus
induce cleavage of the pre-substrate by the enzyme, which would
result in the release of the coumarin ﬂuorophor and generate a
time-dependent increase in ﬂuorescence. The experimental set-up
should enable the parallel testing of several fragments, for
example, in microtitre plates. Determination of the rate of the
enzymatic reaction and its concentration-dependent saturation
will then allow us to determine the stability of the enzyme–
substrate complex (apparent KM) consisting of a protease,
the S1-binding nucleophile fragment and the pre-substrate. The
recorded KM values reﬂect the thermodynamic stabilization of the
fragment–pre-substrate–enzyme complex (through KMrKD and
GrRTlnKM) and thereby quantify the templating effect exerted
by the enzyme, resulting in the shift of the ligation equilibrium.
Thereby, the pre-substrate concept will enable the quantitative
analysis of dynamic ligation reactions of nucleophiles and
electrophiles on protein templates.
N-Glyoxalyl-AMC 1 was designed and synthesized as the ﬁrst
potential pre-substrate, (Fig. 1, Supplementary Fig. 1). In aqueous
solution, 1 is hydrated as indicated by the corresponding acetal
proton at 5.99 pm in the 1H-NMR in acetone/D2O and by the
absence of the aldehyde proton, which can be observed at
10.08 ppm in dimethyl sulfoxide (DMSO) solution. Hydration of
1 is favoured thermodynamically in aqueous solution due to the
electrophilicity of 1 and due to the high concentration of the
water nucleophile (55M). As a result, at physiological pH of 7.4
the equilibrium of ligation reactions of 1 with most O-, N- or
S-nucleophiles providing hemiacetals, imines or thiohemiacetals
as ligation products is on the side of the hydrate—with few
exceptions like aromatic amines. We hypothesized, however, that
despite the favoured hydration of 1, a templating effect exerted by
a ﬁtting protein surface might still enable the formation of
fragment ligation products of 1 and a nucleophile. If these ligation
products can be formed, they might position the amide bond of 1
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in the active site of the enzyme and thereby induce the cleavage of
the pre-substrate. Thus, observing amide bond cleavage of 1 will
prove both the covalent ligation of both fragments and the
templating effect of the protein surface.
As target proteins, two serine proteases were selected, factor Xa
(FXa) and trypsin, two enzymes with well-described preferences
for substrate recognition in the S1 pocket, which is adjacent to the
protein’s active site and thus might be accessible by fragments
ligated to the aldehyde position of 1. The ﬁrst target, FXa, is a
key-player in the blood coagulation cascade and an established
drug target for inhibition of haemostasis. It prefers to cleave
substrates with arginine (Arg) next to the cleavage site34. The
second target, trypsin, not only hydrolyzes peptides with arginine
at P1, but also those endowed with lysine (Lys) at the cleavage site
and plays its major role in digestion in the duodenum35. While
trypsin has a broad substrate tolerance, FXa has rather speciﬁc
substrate requirements.
Proof-of-concept. It was attempted to prove the validity of the
pre-substrate concept with respect to the potential pre-substrate 1
























































































































Figure 1 | The concept of pre-substrate activation by protein-binding fragments. Fragments bind to the S1 pocket of trypsin-like proteases with reported
afﬁnity (a). Only in case where the nucleophile is positioned correctly, ligation of a pre-substrate occurs (b), resulting in cleavage (c) of the formed
substrate and release of the cleavage products (d,e).
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the shortened amino acid substrate Z-Arg-AMC were
incubated with one of the proteases (3.5 nM) in a 50mM 3-(N-
morpholino)propanesulfonic acid buffer (MOPS buffer) at pH 8
and room temperature. For both enzymes a distinct increase in
ﬂuorescence was recorded indicating the efﬁcient turnover of
both substrates. Next, the potential pre-substrate 1 was incubated
with one of the proteases under the same conditions. Even at
concentration up to 12.6mM absolutely no conversion of 1 was
recorded and thus 1 was proven not to be a substrate of either
trypsin or FXa.
Next, 1 (3mM) was incubated in the very same assay with
trypsin (3.5 nM) and a strong excess of N-(2-hydroxyethyl)
guanidine 4 (7.7mM) as a potentially activating nucleophilic
fragment. 4 was selected for this purpose as it was expected to
bind to the S1 site of the protein and could be able to form an
isosteric ligation product with 1, which might position the AMC-
amide bond at the active site of the protease. Indeed, the mixture
of 1 and 4 with each of the proteases produced a time-dependent,
linear increase in ﬂuorescence at 460 nm (Fig. 2b). The observed
effect depended critically on the presence of the protease: pre-
substrate 1 and fragment 4 in buffer without addition of the
protease did not affect cleavage of 1 and an increase in
ﬂuorescence. For another negative control, the non-nucleophilic
control fragment propyl guanidine 14 was incubated with 1 and
the protease at high concentrations. No cleavage of the pre-
substrate was observed under these conditions, either. This
experiment excludes the theoretical possibility that the guanidine
fragment can induce cleavage of the pre-substrate by binding
to S1 without ligating to the pre-substrate. For a secondary
and independent conﬁrmation of pre-substrate activation, the
reaction mixture consisting of pre-substrate 1 (0.3mM), trypsin
and bis-nucleophilic fragment 4 (2-aminoethanol) was analyzed
by high-performance liquid chromatography (HPLC) at different
time points. The ﬂuorescence increase at 430 nm was found to
correlate with cleavage of the amide bond in 1 and the release of
non-acylated AMC (Fig. 2c, Supplementary Fig. 8). Additionally,
possible side reactions of pre-substrate 1 with side chains of
trypsin were excluded using MALDI-ToF/ToF mass spectrometry
(Supplementary Figs 9–11). In summary, these experiments
conﬁrmed that pre-substrate 1, which was completely inactive
towards the protease alone, was activated by covalent dynamic
ligation with nucleophile 4.
Potential pre-substrates and fragments. The scope of the
pre-substrate concept was to be investigated with respect to the
selection of nucleophiles, which undergo the activating ligation
reaction, and with respect to the pre-substrates to be used. In
addition to the ﬁrst pre-substrate, N-glyoxalyl-AMC 1 (2-oxo-N-
(4-methyl-2-oxo-2H-chromen-7-yl)-acetamide), N-malonalyl-AMC
2 (3-oxo-(N-(4-methyl-2-oxo-2H-chromen-7-yl)-propanoylamide)
and N-acryloyl-AMC 3 (N-(4-methyl-2-oxo-2H-chromen-7-yl)-
acrylamide) were designed as potential alternatives (Fig. 3,
Part a). In pre-substrate 2 a methylene bridge was inserted
between the acyl-AMC and the aldehyde functionality, resulting
in fragment ligation products elongated by one carbon. In addi-
tion, the CH acidity at C2 of the malonyl aldehyde should
facilitate the enolization and thereby might favour the formation
of ligation products compared with 1. Acrylamide 3 was chosen




































































Figure 2 | Proof-of-concept. Pre-substrate 1 was completely inactive towards cleavage with trypsin (a, black). Addition of fragment 4, a ligand that
binds to the S1 pocket of trypsin, resulted in the activation of the pre-substrate, cleavage of the amide bond and the release of the reporter dye
7-amino-methyl coumarin (AMC; a, blue). No ﬂuorescence was emitted in the presence of negative control fragment 14 (a, magenta). Formation
of AMC was followed by ﬂuorescence spectroscopy (b) and HPLC (c) and can be rationalized by formation of a hemiacetal ligation product and its
recognition by the protein. The experiments were replicated twice by two different operators with duplicate repeated measures within each replication.
Each data point represents the average of double determination.
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potentially yielding bioactive substrate structures. Both
compounds 2 and 3 were completely stable towards both pro-
teases under assay conditions without nucleophilic fragments,
establishing them as pre-substrates. A small collection of 14
fragments (4–17) was composed containing various N-, O- and
S-nucleophiles (amines, alcohols and mercaptanes) and non-
nucleophilic control fragments as potential mimetics of the
arginine or Lys side chains (Fig. 3, Part b). The already mentioned
N-(2-hydroxyethyl)guanidine 4 was complemented by its
amino- and mercapto-derivatives (5, 6), the diamines 7 and 8 as
potential mimetics of the Lys side chain were complemented
by ethanolamine 9 and 2-mercaptoethanamine 10. 4-(amino-
methyl)benzamidine 11, 4-aminobenzamidine 12 and amino-
guanidine 13 represent further classical mimetics of the arginine
side chain. N-propylguanidine 14, S-ethylisothiourea 15 and
propylamine 16 were selected as negative controls, while
5-chloro-2-thiophenemethanol 17 was included as the fragment
binding to the S1 pocket of FXa in the drug rivaroxaban (Fig. 3,
Part b).
Screening with different nucleophiles. All fragments were
investigated separately at identical concentrations on 96-well
microtitre plates with and without one of the proteases for acti-
vation of the three pre-substrates. No increase of ﬂuorescence was
observed for any of the fragments together without protease in
the reaction buffer. In situ formation of substrates by dynamic
ligation of a fragment and a pre-substrate was detected via release
of the ﬂuorescent reporter molecule, AMC by amide bond
cleavage. AMC-release was followed by excitation at 380 nm and
ﬂuorescence detection at 460 nm. The ﬂuorescence intensity at
460 nm was recorded in each well for a time period of 15min and
the slope was determined for a comparison of all fragment–pre-
substrate combinations. For each of the three pre-substrates,
several activating fragments were identiﬁed, whereas none of
the pre-substrates was activated by one of the negative control
fragments 14–16. Glyoxalyl-AMC 1 was activated by 9 out of
14 fragments to a substrate of trypsin, and by 7 out of 14
fragments to a substrate of FXa. 9 (ethanolamine), 7 (butane-
1,4-diamine), 11 (4-(aminomethyl)benzamidine) and 4
(2-hydroxyethylguanidine) were found to be most active for 1
and trypsin (Table 1, entry 6, 4, 7 and 1), whereas ethanolamine
9, 2-hydroxyethylguanidine 4 and butane-1,4-diamine 7 were
established as the most active molecules for 1 and FXa (Table 1,
entry 6, 1 and 4). Malonalyl-AMC 2 was turned into a trypsin
substrate by 11 out of 14 non-control fragments, and into a FXa
substrate by 10 fragments. In the presence of trypsin, 2 was best
activated by fragments 6 and 9 (Table 1, entry 3 and 6); in the
presence of FXa by fragments 4, 9 and 11 (Table 1, entry 1, 6
and 7). In general, as summarized in Table 1, both the activating
effect of different nucleophiles varied between the pre-substrates
and between the two proteases (Supplementary Figs 5 and 7).



































































Figure 3 | Structure of potential pre-substrates 1–3 and S1-binding fragments 4–17. The details of the synthesis of compounds 1–17 as other



























Figure 4 | Model for the activation of pre-substrates by nucleophilic
protein-binding fragments. One protease molecule, a fragment and a pre-
substrate form a three-component P–F–PS complex, which releases the
coumarin dye AMC as a result of the enzymatic activity of the protease (a).
The apparent KM value, reﬂecting the stability of the P–F–PS complex,
can be derived from the half maximal rate of the enzymatic reaction Vmax/2
as exempliﬁed here for the combination of protease FXa, fragment 7 and
pre-substrate 1 (b).
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the hydroxy-derivatives of the Lys and arginine mimetics, fol-
lowed by the diamines (forming Lys isosters) and then the amino-
substituted guanidines (forming Arg isosters). FXa was more
selective in the acceptance of fragments (and ligation products),
and had distinct preferences with respect to the strength of
activation.
Next, a quantitative description of the observed activation of
pre-substrates by nucleophilic fragments and of the templating
effect exerted by the enzymes was to be established. For the
purpose, a modiﬁed Michaelis–Menten model for enzymatic
reactions was adapted to the special case of pre-substrate
activation. In this model, the protease P was expected to bind a
nucleophilic fragment F in its S1 pocket, which reacted in a
dynamic and covalent ligation reaction to form the three-
component protease–fragment–pre-substrate (P–F–PS) complex.
Taking into account the S1 afﬁnity of the employed nucleophiles
and the non-detectable binding of the pre-substrates to the
protein alone, one can assume that the binding of the nucleophilic
fragment is the initial step of the complex formation. The P–F–PS
complex is then converted by the enzyme yielding free AMC as
the detectable product. Experimentally, the rate of the enzymatic
reaction, V, corresponding to the cleavage of the ligation product
can be determined. When V was measured at a ﬁxed pre-
substrate concentration (3mM), the saturation of the reaction
rate to Vmax could be determined for increasing fragment
concentrations. The fragment concentration at the half maximal
rate (Vmax/2) was considered as the apparent KM value (KM*) of
the ligation product and indicates the stability of the enzyme–
ligation product complex, the P–F–PS complex (Fig. 4).
It should be noted that the thermodynamic stabilization of the
P–F–PS complex expressed as KM* value is a direct measure for the
templating effect exerted by the enzyme, which corresponds to
the free energy of complex formation and describes the shift in
the equilibrium from the free fragments to the ligated fragments.
Determinations of both KM and Vmax values were conducted for
the seven most active fragments, two pre-substrates and two
enzymes (Table 1). The apparent KM values of the three-
component P–F–PS complexes varied between 130 mM (for the
combination of PS 2, F 9 and FXa as protease) and ca. 6mM
(for the combination of PS 1, F 6 and trypsin). The Vmax values
were between 12.9 mMmin 1 (PS 1, F 4 and FXa) and
242.3 mMmin 1 for the combination of PS 2, F 7 and FXa. No
stringent correlation between the KM and Vmax values was
observed for both enzymes and pre-substrates, however, in most
of the cases, the Vmax was higher with PS 2; in 11 out of 14 cases it
was more than twofold. The kinetic analysis of pre-substrate
activation revealed that the reaction process was catalytic in a
double sense. Not only the proteases but also the nucleophilic
fragments themselves acted as catalysts in the conversion of the
pre-substrate without being consumed or modiﬁed in the process.
While the catalytic action of proteases as enzymes was expected,
the organo-catalytic effect36,37 of the protein-binding nucleophile
was remarkable, as it constitutes to our best knowledge the
ﬁrst example of a catalytic activity of a small molecule in a
protein-templated reaction.
Michael addition ligation. The third pre-substrate,
N-acrylamido-AMC 3, was selected as a model for irreversible
pre-substrate activation. Activation of 3 was investigated in the
presence of thiol nucleophiles, which were expected to yield
Michael addition products being stable under assay condi-
tions38,39. Thus, pre-substrate 3 was incubated with one of three
thiol nucleophiles, 2-mercaptoethyl-guanidine 6, cysteamine 10
and 4-amino benzenethiol in the assay buffer for 30min at room
temperature (20 C). Subsequently, trypsin was added and
time-dependent ﬂuorescence was recorded at 480 nm (Fig. 5).
The thiol fragments 6 and 10 were active and led to the release
of AMC, while no activation was observed with the negative
control fragment, 4-aminobenzenethiol. For an independent
conﬁrmation of the observed pre-substrate activation, the
Michael addition product 18, formed by reaction of cysteamine
10 and presubstrate 3 was synthesized at 35 C (Supplementary
Fig. 4), isolated and tested in the presence of trypsin. leading to a
comparable release of AMC (Fig. 5, method B). Thus, it has been
demonstrated that the activation of pre-substrates can be effected
not only by reversible but also by irreversible ligation reactions.
Three-fragment assembly. Finally, it was investigated, if the pre-
substrate concept could be extended further from two-fragment
assemblies as demonstrated above to the protein template-
assisted formation of bioactive assemblies consisting of three-
components. This investigation was based on the following
consideration. Pre-substrate 2 was found to be activated
efﬁciently by butane-1,4-diamine 7. If one assumes that this
activation proceeds via formation of the amino-butyl-imine 19 as
the substrate and reversibly formed two-fragment assembly, one
can hypothesize that a third fragment might be able to add to the
imine 19, yielding an assembly of three fragments with potentially
enhanced substrate activation (Fig. 6). To test this hypothesis,
Table 1 | Quantitative determination of pre-substrate activation.
Entry Fragment* Trypsin FXa













1 4 1.55±0.6 27.49±2.82 2.53±1.56 33.09±7.39 2.25±0.65 12.91±1.66 2.84±0.56 86.59±5.20
2 5 1.96±1.5 40.43±8.36 0.94±0.14 52.37±1.53 3.15±0.71 15.00±2.39 2.48±0.83 73.90±07.10
3 6 5.97±0.4 26.75±2.73 0.5±0.26 91.24±7.47 2.96±0.9 43.82±18.13 1.93±0.71 120.01±9.93
4 7 2.08±0.5 17.54±1.42 0.94±0.32 136.33±8.84 2.68±0.91 58.48±5.94 3.63±0.98 242.28±10.90
5 8 2.01±0.4 26.63±1.74 2.33±1.21 79.32±11.62 2.4±1.2 19.06±2.78 2.847±1.1 174.15±2.60
6 9 1.92±0.8 22.61±2.61 0.15±0.06 66.11±2.14 1.64±0.11 35.18±5.73 0.13±0.07 73.06±2.52
7 11 0.32±0.2 38.55±3.62 0.3±0.15 39.31±2.38 2.24±1.1 13.18±1.99 1.82±0.73 29.13±3.02
FXa, factor Xa.
Apparent KM
* values and Vmax rates for the various combinations of serine proteases, pre-substrates and nucleophilic fragments.
No activation of pre-substrates was detected with fragments 14, 15 and 16. Relative ﬂuorescence units (RFUs; l 460nm) were determined as 47.465 RFU per mMAMC (Supplementary Fig. 6).
The experiments were replicated twice by two different operators. Each data point represents for the average of double determination. Error bars indicate s.e. (Supplementary Figs 5 and 7).
*Only low activation was detected by fragments 10, 12, 13 and 17 (results not shown).
wPre-substrate 1.
zPre-substrate 2.
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fragment 7 was incubated with one of the two proteases
(trypsin or FXa), pre-substrate 2 and either 6 or 10 as third
fragments. As described above, fragment 6, 7 and 10 activated the
pre-substrate 2 when added as secondary fragment. Addition of
the third fragment generated for both enzymes and for both thiol
fragments stronger AMC ﬂuorescence. For trypsin, the strongest
activation of pre-substrate 2 was observed with fragments 7 and
10 by 56% or 50 relative ﬂuorescence units (RFUs) after 15min
(Fig. 6a); for FXa, the combination of 2 with 7 and 6 resulted in
the strongest activation by almost 100% or 80 RFU after the same
time (Fig. 6b). In both cases, the activation by three fragments
was compared with activation of a doubled concentration of
fragment 7 (15mM instead of 7.5), which yielded no or low
increase in ﬂuorescence, indicating that there was indeed an
enhancing effect of the third fragment added.
Discussion
It has been demonstrated that protein-binding small molecule
fragments can induce chemical reactions on the protein surface in
a catalytic process. Nucleophilic, low molecular weight fragments
binding to the S1 pocket of serine proteases were able to activate
electrophilic pre-substrates in a protein-templated reaction.
Activation of pre-substrates occurred via a dynamic covalent
ligation reaction on the protein surface and both the free
nucleophile and the presence of the enzyme were essential for this
process. The reversible ligation reaction of the protein-bound
amino-, hydroxy-, or mercapto-nucleophile with the electrophile
positioned the pre-substrate into the active site of the enzyme and
thereby induced the enzymatic hydrolysis of the protein–
fragment–pre-substrate assembly. The activation process was
studied quantitatively with three pre-substrates containing
N-acylated AMC as a ﬂuorogenic dye, which upon hydrolysis
released the ﬂuorophore 7-amino-methyl coumarin. The cleavage
reaction was monitored by ﬂuorescence spectrometry.
The mechanism of pre-substrate activation was conﬁrmed by
the results of several control experiments. Only S1-binding
fragments containing a free nucleophile available for dynamic
covalent ligation were able to activate pre-substrates. No cleavage
of the pre-substrate was observed without presence of a protease.
Second, HPLC analysis of the assay solution revealed that the
increase in ﬂuorescence indeed correlated with the hydrolytic
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Method B:
pre-synthesis,
DTT, 0.5 h, 35°C
 H2O, 70% conversion
Figure 5 | Activation of pre-substrate 3. (a) Reaction scheme.
(b) Recorded ﬂuorescence of released AMC over time. Inﬂuence of ligation
product (in situ formed from 3 and 10, method A, blue) in comparison with
isolated substrate 18 on the enzyme activity (method B, magenta). The
experiments were repeated twice by two different operators with duplicates
measured within each replication. Each data point represents the average of
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Figure 6 | Three-fragment assembly. Inﬂuence of nucleophilic fragments 7, 6 and 10 and pre-substrate 2 on the enzyme activity; (a) trypsin, (b) factor Xa.
The experiments were replicated twice by two different operators. Each data point represents the average of double determination.
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coumarin. The rate of the pre-substrate cleavage (V) was
measured as a function of the fragment concentration for all
combinations of one of eight active fragments with one of two
pre-substrates and proteases. In all cases, the substrate cleavage
rate V increased with growing fragment concentrations and could
be saturated when approaching the maximal conversion rate
(Vmax). The stability of the protease–fragment–pre-substrate
(P–F–PS) complex, KM* , was determined for each of the tested
P–F–PS combinations as the fragment concentration at the half
maximal velocity (Vmax/2). The stability of the P–F–PS complex is
a direct measure for the free enthalpy of complex formation and
thus the KM* values indicate quantitatively the shift in the ligation
equilibrium exerted by the enzyme’s templating effect. Both
the Vmax and the KM* values were speciﬁc for each of the tested
P–F–PS combinations, suggesting both a speciﬁc recognition
effect exerted by the protease and a speciﬁc catalytic activation
effect of the bis-nucleophile. No correlation between the stability
of the P–F–PS complex and the maximal cleavage rate was
observed, however, the cleavage rates were consistently higher for
pre-substrate 2 compared with pre-substrate 1, suggesting that
the latter compound ensures—at least for the activating fragments
tested here—a better positioning of the cleaved amide bond in the
active site of the enzyme.
The pre-substrate concept was further extended from reversible
towards irreversible, covalent fragment ligations as demonstrated
with the Michael addition of thiol nucleophiles to the acrylamide
containing pre-substrate 3. Finally, pre-substrate activation was
conducted not only by dimeric ligations (with two fragments) but
also using hetero-trimeric fragment assemblies, if one amine and
one thiol nucleophile were employed.
The reported activation of pre-substrates constitutes a novel
approach to identify small molecule fragments binding speciﬁ-
cally to deﬁned protein-binding pockets. The described assays—
demonstrated here for the S1-pockets of two proteases, trypsin
and FXa—enable the quantitative detection of protein-templated
ligation reactions. The templating effects responsible for shifting
the ligation equilibrium can be determined quantitatively. One
would further expect that the activation of pre-substrates can be
applied to other proteases as well and can be extended towards
other secondary binding sites and towards other classes of
hydrolytic enzymes, whenever a protein-bound primary fragment
is capable to react with a secondary fragment and thereby direct
cleavable bond at the active site of the protein. The assays can be
extended to the screening of larger libraries of nucleophilic
fragments and the sensitized detection of fragments binding to
deﬁned pockets of enzymes might serve as a starting point for the
development of site-directed inhibitors of these enzymes as well.
Libraries of nucleophilic fragments are smaller and less diverse
than unbiased fragment libraries. On the other hand, presence of
a nucleophilic functionality in all hits of a pre-substrate screen
will facilitate the subsequent extension of hit fragments, possibly
in an iterative ligation screening step.
Beyond its practical implications, pre-substrate activation by
protein-binding nucleophiles constitutes an example for a
coupling of dynamic covalent ligation reaction with an enzymatic
reaction. The protein-binding nucleophilic fragments act as
organo-catalysts for the hydrolysis of the pre-substrate by the
enzyme. Such organo-catalytic reactions of protein-binding
fragments in fact enlarge the substrate pool of enzymes by pre-
substrates and thereby extend the realm of exploitable enzymatic
reactions.
Methods
General methods. The details of the synthesis of compounds 1–18
(Supplementary Figs 1–4) as other methodological information are reported in the
Supplementary Methods. The activity of the serine proteases was determined by
measuring the release of AMC from the ﬂuorogenic substrate synthesized in situ on
96-well microtitre plates using a Tecan Saﬁre2 wellplate reader. The excitation
wavelength was set to 380 nm and emission was recorded at 460 nm. For the
analysis of the data, GraphPad Prism 5 was used. Purity characterization of trypsin
and FXa and also the investigation of side reactions between pre-substrate and
proteins were analyzed using MALDI-MS. MALDI-ToF/ToF MS was performed on
Ultraﬂex III, Bruker Daltonics 2007 equipped with a smartbeam laser (Nd:YAG).
SDHB (mixture of 2,5-dihydroxybenzoic acid and 2-hydroxy-5-methoxybenzoic
acid) or CA (alpha-cyano-4-hydroxycinnamic acid) from Bruker Daltonics were
used as matrix materials. Buffers and reagents were purchased from Roth and
Sigma-Aldrich. Water was puriﬁed by ultraﬁltration (Millipore Simplicity 185).
Human FXa was obtained as lyophilized powder by Enzyme Research Laboratories
Ltd (Catalogue: HFXa 1011, activity: 228 IUmg 1) and dissolved in BisTris-buffer
(bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane, pH 6). Bovine trypsin
was acquired by Sigma-Aldrich as lyophilized powder (T1426 Sigma, TPCK trea-
ted, essentially salt free, 4100,000 BAEE Umg 1 protein) and taken up in 1mM
HCl. MOPS-NaOH buffer pH 8 was prepared in ultra pure water. 3-(N-morpho-
lino)-propanesulfonic acid (MOPS, 50mM) and NaCl (154mM) were dissolved in
water; pH was adjusted with NaOH (stored at 4 C).
DLS procedures. First procedure. Pre-substrate activation by nucleophilic protein-
binding fragments. First screening procedure was performed using the pre-sub-
strate 1 or 2 (3ml of 233mM stock solution in DMSO resulting in 3.07mM assay
concentration) and one of the various nucleophilic fragments 4–17 (3 ml of 0, 60,
240, 580 or 1,160mM stock solution in DMSO resulting in 0, 0.77, 3.2, 7.7 or
15.4mM assay concentration) in a total volume of 206ml MOPS-NaOH buffer
(pH 8, 50mM) per well. Fluorescence was monitored starting immediately after the
addition of 20ml of the serine protease solution (3.5 nM trypsin or 3.5 nM FXa;
1/1,000 dilution in bovine serum albumin (BSA) 0.1% (wt/vol), NaCl 154mM).
The initial rates were determined and plotted against the fragment concentration
(Supplementary Figs 5 and 7).
Second procedure. Three-fragment assembly screening. The three-fragment
assembly screening was investigated using pre-substrate 2 (3 ml of 233mM DMSO
stock solution equates to 3.07mM assay concentration) and fragment 7 (3 ml of 580
or 1,160mM DMSO stock solution equates to 7.7mM or 15.4mM assay
concentration) in a total volume of 206 ml MOPS-NaOH buffer (pH 8, 50mM).
After incubation (30min, room temperature) the second nucleophilic fragment 6
or 10 (3 ml of 580mM DMSO stock solution equates to 7.7mM assay
concentration; Fig. 2, Part b) and 20 ml of the serine protease solution (3.5 nM
trypsin or 3.5 nM FXa; dilution in BSA 0.1% (wt/vol), NaCl 154mM) was added.
The ﬂuorescence intensities were plotted over time (Fig. 6).
Third procedure. Michael addition screening. Third screening procedure was
performed using pre-substrate 3 (3 ml of 233mM DMSO stock solution equates to
3.07mM assay concentration) and cysteamine 10 (3ml of 580mM DMSO stock
solution equates to 7.7mM assay concentration) in a total volume of 206ml MOPS-
NaOH buffer (pH 8, 50mM). After incubation (30min, 35 C) 20ml serine protease
(3.5 nM trypsin or 3.5 nM FXa; dilution in BSA 0.1% (wt/vol), NaCl 154mM) was
added. Relative ﬂuorescence was recorded and plotted against the time (Fig. 5). For
comparison the addition product 18 was pre-synthesized. Twenty microlitres of
serine protease (3.5 nM trypsin or 3.5 nM FXa; dilution in BSA 0.1% (wt/vol), NaCl
154mM) was added to the isolated compound 18 (5ml of 140mM DMSO stock
solution equates to 3.01mM assay concentration) in a total volume of 205 ml
MOPS-NaOH buffer (pH 8, 50mM). The measurement was started without
secondary incubation.
Determination of RFUs. For the determination of RFUs, the ﬂuorescence of AMC
was measured at different concentrations. RFUs (RFUs; l 460 nm) were found to
correlate linearly with the AMC concentration at concentration between 0 and
8mM. The calculation factor was determined as being 47.465 RFU per mMAMC and
the initial rates in mMmin 1 were plotted against the fragment concentrations
(Supplementary Fig. 6).
HPLC investigations. Twenty microlitres of trypsin (3.5 nM; dilution in BSA 0.1%
(wt/vol), NaCl 154mM) was added to pre-substrate 1 (20ml of 4mM stock solution
equates to 0.307mM assay concentration) and fragment 4 (20ml of 12mM stock
solution equates to 0.92mM assay concentration) in total volume of 240 ml distilled
water and mixed over 0, 5 and 25min. Next, 260 ml acetonitrile was added to the
probes, mixed and analyzed by HPLC. The turnover frequency (TOF) refers to the
trypsin and was calculated on the basis of the amount of the product formed as well
as the amount of trypsin used per minute. The reaction was detected at 340 and
430 nm (Supplementary Fig. 8).
MALDI-TOF/TOF MS investigations. Purity characterizations. Trypsin (10.2 mM;
dilution in water) and FXa (42.6 mM; dilution in water) were analyzed separately
with SDHB (mixture of 2,5-dihydroxybenzoic acid and 2-hydroxy-5-methox-
ybenzoic acid) or cinnamic acid (CA) matrix material (Supplementary Figs 9
and 10).
Investigation of side reactions between trypsin and pre-substrate 1. Twenty
microlitres of trypsin (10.2mM, dilution in water) was incubated with 2 ml
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pre-substrate 1 (100 mM, dilution in water). The reaction mixture was analyzed
using CA matrix material.
Investigation of side reactions between trypsin, pre-substrate 1 and fragment 4.
Twenty microlitres of trypsin (10.2 mM, dilution in water) was incubated with 2 ml
pre-substrate 1 (100 mM, dilution in water) and 2 ml fragment 4 (100 mM, dilution
in water). The reaction mixture was analyzed using CA matrix material;
(Supplementary Fig.11).
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